Rossari Biotech Limited (NSE:ROSSARI)

Rossari Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 23, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	29,547	33,476	37,399	32,878	50,189	53,775
Market Cap Growth	-30.40%	-10.49%	13.75%	-34.49%	-6.67%	-
Enterprise Value	32,306	34,283	37,924	32,853	49,805	52,708
Last Close Price	533.50	604.19	676.07	594.90	909.24	1032.50
PE Ratio	21.47	24.55	28.62	30.65	51.39	67.04
Forward PE	19.13	21.24	24.16	21.14	32.93	53.73
PS Ratio	1.29	1.61	2.04	1.99	3.38	7.58
PB Ratio	2.36	2.82	3.57	3.59	6.23	13.16
P/TBV Ratio	2.90	3.56	4.76	5.13	9.22	13.60
P/FCF Ratio	-	-	-	27.70	-	-
P/OCF Ratio	-	24.36	86.46	21.69	170.96	112.58
PEG Ratio	1.53	1.81	1.81	1.81	1.81	2.07
EV/Sales Ratio	1.41	1.65	2.07	1.98	3.36	7.43
EV/EBITDA Ratio	12.25	13.79	15.68	15.37	28.17	42.87
EV/EBIT Ratio	16.56	18.31	20.76	21.67	38.54	52.58
EV/FCF Ratio	-	-	-	27.68	-	-
Debt / Equity Ratio	0.28	0.18	0.11	0.08	0.01	-
Debt / EBITDA Ratio	1.34	0.86	0.49	0.34	0.05	-
Debt / FCF Ratio	-	-	-	0.62	-	-
Asset Turnover	-	1.20	1.25	1.26	1.63	1.37
Inventory Turnover	-	4.52	5.53	6.22	7.80	6.05
Quick Ratio	-	1.10	1.17	1.45	1.25	1.55
Current Ratio	-	1.94	1.99	2.07	2.07	2.36
Return on Equity (ROE)	-	12.21%	13.32%	12.47%	16.10%	23.02%
Return on Assets (ROA)	-	6.75%	7.77%	7.22%	8.88%	12.13%
Return on Invested Capital (ROIC)	9.38%	11.58%	13.90%	14.20%	17.19%	28.39%
Return on Capital Employed (ROCE)	-	13.80%	15.90%	14.90%	13.40%	24.40%
Earnings Yield	4.66%	4.07%	3.49%	3.26%	1.95%	1.49%
FCF Yield	-	-0.63%	-2.35%	3.61%	-0.18%	-0.19%
Dividend Yield	0.09%	0.08%	0.07%	0.08%	0.06%	0.05%
Payout Ratio	-	2.03%	2.11%	2.57%	2.82%	3.16%
Buyback Yield / Dilution	-0.10%	-0.08%	0.05%	-0.33%	-6.37%	-5.16%
Total Shareholder Return	-0.00%	0.00%	0.13%	-0.24%	-6.31%	-5.12%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.